Compare Exelon’s grid focused plan with other regulated utilities by scanning our hand picked 41 power grid technology and infrastructure stocks, which are also pouring capital into transmission and infrastructure projects.
For an investor to stay in Exelon, the core belief is that a heavily regulated grid utility can keep turning a large, long dated capital plan into stable earnings and cash flows. The latest quarter showed higher sales but lower net income and EPS versus last year, which keeps attention firmly on execution of the US$41.7b grid program as the near term swing factor.
The biggest short term catalyst is progress on transmission and storage projects that support Exelon’s reaffirmed 5% to 7% operating EPS growth target from 2025 to 2029. The main risk is that regulators or affordability concerns slow rate approvals, leaving returns lagging spending and squeezing margins while interest costs remain a watch point.
The guidance reaffirmation is the announcement that matters most here. Management backed a plan for operating EPS compounded annual growth near the top end of 5% to 7% from 2025 to 2029. That signal anchors the grid buildout story and frames how investors think about the link between the US$41.7b capital plan and future earnings power.
For you as a shareholder, that guidance keeps the focus squarely on project delivery, regulatory settlements and cost control rather than on rewriting the Exelon investment case. If rate cases, customer affordability or credit metrics undercut that 5% to 7% path, the thesis weakens. If the utility keeps lining up approvals and holding O&M growth to planned levels, the long term narrative remains intact.
Exelon’s narrative projects US$27.8b revenue and US$3.6b earnings by 2029, based on analyst models. This implies 3.2% yearly revenue growth and an earnings increase of about US$0.8b from current earnings of roughly US$2.8b.
Uncover why Exelon's fair value indicates a 3% potential upside to its current price that could narrow quickly.
The Simply Wall St Community only contributes two fair value views for Exelon, yet they sit far apart, from about US$12.95 to US$47.59 per share. That spread shows how differently retail investors weigh the reaffirmed capital plan against regulatory and affordability pressure. You can use these contrasting opinions to test your own assumptions.
Explore another Exelon fair value estimate, including one that suggests it could be worth as much as $47.59.
Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.
If the Exelon story has sharpened your thinking on regulated utilities and long term compounding, it can be useful to contrast it with other types of opportunities using the Simply Wall St Screener.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com